How Public Opinion Monitoring Services Are Reshaping Chinese Media
The China Quarterly · 25.06.2026 · 1-17
DOI: 10.1017/s0305741026102483 ↗Kurz gefasst
Fachartikel in der Zeitschrift The China Quarterly, online erschienen am 25.06.2026. Verfasst von Haiyan Wang und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Faced with the pressures of digital transformation, media organizations in China are undergoing a “think-tank turn,” in which Public Opinion Monitoring Services (POMS) are playing an integral role. This study uses POMS as a case to examine the digital transformation of Chinese media organizations and to explore the broader shifts in the political economy of Chinese media in the digital age. Combining in-depth interviews, fieldwork and analysis of secondary documents, this qualitative research study identifies the emergence of consulting as a “third role” of Chinese media, supplementing the traditional roles of news reporting and ideological propagation. This new role caters to the government’s need to govern the online space and manage public opinion through three primary operations: “timely firefighting” against dissident voices, “regular monitoring” of public opinion and the “periodic training” of information officials. In this context, POMS not only enable media organizations to navigate financial challenges but also significantly reshape their role and relationship with the state.
Zitieren
APA
Wang, H., Huang, C., & Yin, L. (2026). How Public Opinion Monitoring Services Are Reshaping Chinese Media. The China Quarterly, 1-17. https://doi.org/10.1017/s0305741026102483
Vancouver
Wang H, Huang C, Yin L. How Public Opinion Monitoring Services Are Reshaping Chinese Media. The China Quarterly. 2026:1-17. doi:10.1017/s0305741026102483
BibTeX
@article{Wang2026,
author = {Wang, Haiyan and Huang, Chunyan and Yin, Liangen},
title = {How Public Opinion Monitoring Services Are Reshaping Chinese Media},
journal = {The China Quarterly},
year = {2026},
pages = {1--17},
doi = {10.1017/s0305741026102483}
}
EUVIMED